[Duodenal ulcer treated by carbenoxolone sodium. Endoscopically controlled trial (author's transl)].
The authors present the results of a clinical and endoscopic controlled trial of outpatients with duodenal ulcer treated with carbenoxolone (CBX) and carbenoxolone plus antacids (CBX + AA). They observed complete healing of the duodenal ulcer in 77%-83,3% in both groups of patients. They concluded that CBX is important in the treatment of duodenal ulcer been equally effective alone or in association with antacids.
D000863:Antacids / Q000627:therapeutic use*; D002229:Carbenoxolone / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000175:diagnosis / Q000188:drug therapy*; D004724:Endoscopy; D005336:Fiber Optic Technology; D006034:Glycyrrhetinic Acid / Q000031:analogs & derivatives*; D006801:Humans; D013607:Tablets
D000863:Antacids; D013607:Tablets; D002229:Carbenoxolone; D006034:Glycyrrhetinic Acid
Tratamento da úlcera duodenal com carbenoxolona sódica. Estudo controlado endoscópico.